Pages

Thursday, June 21, 2007

Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug

Perhaps the initial panic selling of Monogram Biosciences stock this morning shouldn't be surprising. Monogram manufactures a diagnostic test used to identify HIV patients who would respond to Pfizer Inc's maraviroc drug, which didn't get the expected FDA approval on June 20.

mgrmpn777

2 comments:

  1. Anonymous6/21/2007

    dr. rost,
    any interesting mail this past weekend?

    ReplyDelete
  2. Anonymous6/21/2007

    hmmm cryptic...I know everyone knows Pfizer has been propping Monogram up for quite awhile so in reality what you have is a paper tiger without Pfizer they may be caput....

    ReplyDelete